BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 31 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 31 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT
Analysis

Yirendai slips as operational weakness overrides Q4 earnings beat

China-based fintech firm Yirendai (YRD) showed broad-based weakness in the fourth quarter, sending its stock down 3.9% during pre-market trading on Monday. Investors remained unmoved by the adjusted earnings of $1.32 per ADS in Q4, much higher than the street projection of 51 cents per ADS. Hurt by a decline in loan origination volume, total […]

March 25, 2019 2 min read

China-based fintech firm Yirendai (YRD) showed broad-based weakness in the fourth quarter, sending its stock down 3.9% during pre-market trading on Monday. Investors remained unmoved by the adjusted earnings of $1.32 per ADS in Q4, much higher than the street projection of 51 cents per ADS.

Hurt by a decline in loan origination volume, total net revenue in the fourth quarter tumbled 30% to $184.8 million.

The company facilitated $1.217 billion worth of loans during the quarter through its online market place, over 31% of which were generated by repeat borrowers. The amount of loan facilitated represents a 38% decline compared to last year.

YRD stock has wiped out over 70% of its value in the trailing 52 weeks. Since the beginning of this year, though, it has recovered somewhat and has gained 6.5%.

READ: NOKIA SHARES PLUNGE AFTER COMPANY WARNS OF COMPLIANCE ISSUES

ADVERTISEMENT

CEO Yihan Fang said, “Demand for our wealth management product continues to be strong, close to half a million retail investors chose to invest in our platform this year despite volatilities in the industry and we continue to see average AUM per investor increasing.”

“Going into 2019,” CFO Dennis Cong said,  “we will maintain focused on continual diversification in funding sources, expanding our loan product mix as well as enhancing our risk management strategies to support our credit and wealth management business growth.”

 

Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT